Cannabis companies have slashed over 1,000 jobs in recent weeks as the industry contends with a ‘toxic’ landscape. We’re keeping track of all the cuts here.

Melia Robinson

Company: Pax Labs

What it does: Maker of cannabis vaporizers, based in San Francisco.

Layoffs: 65 workers, or 25% of its workforce in October.

What went wrong: Fallout from the spate of vape-related lung injuries — which have caused 34 fatalities in the US so far — has affected the cannabis industry.

Prior to that, Pax had been something of an investor darling this year, landing a $420 million funding round in April from a range of institutional investors including Fidelity and Tiger Global Management. The round, first reported by The Information, pushed the company into unicorn territory, valuing it at $1.7 billion.

Pax in September let go of its CEO, Bharat Vasan, after a little over a year on the job.

In an interview with Business Insider in January, Vasan said the company was talking to bankers about a potential IPO in 2020. That seems to not be the case anymore, according to statement Pax gave to Crunchbase News.

“[A]ny talk of an IPO timeline was premature,” Pax’s head of communications, Dianne Gleason, said.